SITES PATIENTS

Operational Complexity in Cell and Gene Therapy Trials

Applied Clinical Trials

As advanced therapy technology and manufacturing evolve, there are three key operational challenges to address unique to these products.

Advanced therapies (ATs) such as cell therapy, gene therapy, and tissue engineering represent a groundbreaking force in medicine and research. Whereas traditional therapies may use small molecule chemical or biologic products to treat disease, ATs use cells with specifically modified DNA or RNA components to systemically control a disease, replace an aberrant gene, or repair defective tissue. These cellular investigational products have the potential to cure a disease. It is this potential of eliminating disease that could make ATs so revolutionary.

READ MORE

Take Advantage of OncoBay’s Innovative Approach

CONTACT ONCOBAY CLINICAL

Submit a Request for Proposal

Submit Proposal

OncoBay is now Kapadi

 

Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.

 

Visit Kapadi.com

 

This window will auto-close in 15 seconds.

This will close in 7 seconds